Unternehmen auf Beobachtungsliste setzen
Cantourage Group SE
ISIN: DE000A3DSV01
WKN: A3DSV0
Über
Snapshot Unternehmen
Neu: Benachrichtigung aktivieren
Aktuelle Nachrichten per Alarm empfangem
Neu: KI-Factsheet

Coming soon: Zusammenfassung der Unternehmensnachricht durch KI/p>

Cantourage Group SE · ISIN: DE000A3DSV01 · Newswire (Analysten)
Land: Deutschland · Primärmarkt: Deutschland · EQS NID: 22648
19 Mai 2025 09:00AM

NuWays AG: Cantourage Group SE | Rating: BUY


Original-Research: Cantourage Group SE - from NuWays AG

19.05.2025 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Cantourage Group SE

Company Name: Cantourage Group SE
ISIN: DE000A3DSV01
 
Reason for the research: Update
Recommendation: BUY
from: 19.05.2025
Target price: EUR 13.00
Target price on sight of: 12 months
Last rating change:
Analyst: Christian Sandherr

Growth further accelerating, € 100m sales in reach; chg.

April turned out to be yet another record month with sales having reached € 11.1m, a yoy increase of roughly 250%, surpassing the previous record month March (€ 10.7m). This increase should largely be the result of successful de-bottlenecking efforts on Cantourage’s side during the past few months, which began positively impacting the group's top-line from last month onwards. With strongly growing demand, the company has been working on raising its processing capacities at its German site as well as through partnerships (e.g. with a Portuguese contract manufacturer).

€ 100m annual sales in sight. While management has so far not issued a FY25 guidance, we would expect it to point towards the € 100m sales level, in line with our new sales estimate. Reaching € 100m sales would require monthly sales of some € 8m, which looks achievable in light of the recent operating developments.

Scale to kick in. While the company did not announce profitability figures, the strong sales growth should feed down to EBITDA. Taking into account last year's margin (eNuW: 7.5%) and the operating developments since the start of the year, the FY25 EBITDA margin looks set to surpass 10% despite ongoing investments into growth.

Share price de-coupled from fundamentals. Despite expected FY25e sales growth of 94% yoy, Cantourage should be able to reach a 10% EBITDA margin, implying an attractive EV/EBITDA multiple of 5.8x. We confirm our BUY rating with a € 13 PT based on DCF.

You can download the research here: http://www.more-ir.de/d/32648.pdf
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


2139996  19.05.2025 CET/CEST






Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency · Reliability · Credibility
Information regarding Product Information
Montag, 19.05.2025, Kalenderwoche (KW) 21, 139. Tag des Jahres, 226 Tage verbleibend bis EoY.